The company's free
cash flow outlook indicates that it could buy more meaningful assets.
JACOB SONENSHINE DEC 4, 2019 3:16 PM EST
United
Healthcare's recent Investor Day left analysts largely more positive on the
stock than they were before that event.
And
one analyst flags as distinctly possible a particular prospect: United
Health could make more acquisitions, even shortly after its successful --so far
-- purchase of Optum.
At the
managed-care giant's Investor Day, the New York company said it's forecasting 2020 adjusted earnings per share of
between $16.25 and $16.55, with the midpoint of $16.40 missing
analysts estimates of $16.46 by 3%. Nonetheless, at least six analysts raised
their price targets on the stock.
UNH
guided for revenue of between $260 billion and $262 billion, better than
analysts' expectation of $260.2 billion.
Analysts
are also quick to note that UNH usually guides conservatively, as it has
beaten EPS expectations for the past eight quarters.
Adding
to the optimism, "With about $17 billion of free cash flow in 2020, the
company has ample flexibility to pursue acquisitions," wrote Cantor
Fitzgerald analyst Steven Halper in a note.
Analysts polled by FactSet expect
United Health to generate $17.89 billion of free cash flow in 2020, which would
be 17% growth year-over-year.
Halper added, "Over the
years, UNH has had a strong strong acquisition and capital redeployment track
record. We do not expect 2020 to be any different."
Baked into the guidance and
analyst optimism that UNH can soon accelerate earnings growth is Optum. United
bought Optum in 2011 and built the business. Analysts now expect Optum
to account for half of United's earnings in 2020, as the
services unit is expected to serve as the primary growth driver for the
parent.
The key synergy is that Optum not
only provides additional revenue streams, but it gathers customer data, which
enhances the legacy insurance business.
Broadly speaking, the combo can
help move United's annual earnings growth back toward its long-term goal of 13%
to 16%. Management's 2020 guidance implies a 9% growth rate, which does include
a 50-cent-per-share negative impact from the return of health insurance
fees.
Zev Fima, research analyst for
Jim Cramer's Action
Alerts Plus, posits that smaller acquisitions are more likely.
"Given the company's robust
cash flow, we could certainly see some acquisitions in 2020," Fima said.
"Chances are those would be more tuck-in type acquisitions rather than
anything groundbreaking. But even that can be viewed as an incremental positive
as UnitedHealth can bring its massive data hoard to any potential acquisition
and, as a result, likely achieve things that those businesses couldn't on their
own, simply thanks to United Health's massive scale and reach."
https://www.thestreet.com/investing/united-health-dec-4
No comments:
Post a Comment